ICOC Application Review Subcommittee Meeting – May

Return to CIRM Meetings and Events

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS OVERSIGHT COMMITTEE AND
THE APPLICATION REVIEW SUBCOMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Date: May 25th, 2017
Time: 11:00am to 12:00pm

Main Location:

• CIRM 1999 Harrison Street Suite 1650, Oakland, CA 94612

Other Locations:

• 1180 Veterans Blvd, South San Francisco, CA 94080
• 2619 Montclair Street San Diego, CA 92104
• 9301 Wilshire Blvd. Suite. 507 Beverly Hills, CA 90210
• 4005 N. Fresno Street Fresno, CA 93726
• 10996 Torreyana Road, Suite 200  San Diego, CA 92121
• 8170 Laguna Bl, Elk Grove, CA 95758
• 15775 Gum Tree Lane Los Gatos, CA 95032
• 2007 Redwood Rd., Napa, CA 94558
• Room 1105, Gillespie Neuroscience Research Facility 837 Health Science Road Irvine, CA 92697-4292
• 765 Market St. #31 D, San Francisco, CA 94103
• 11440 San Vicente, Los Angeles CA 90049
• 3440 Viking Drive Sacramento, CA 95827
• 1 Dr. Carlton B. Goodlett Place, Room 207 SF CA 94102

Dial In Information

Dial In: (800) 230-1096 
Confirmation Number: 424231​

WebEx Link:

 https://cirm.webex.com/cirm/onstage/g.php?MTID=e43ddd14cc541e35678731d3f746b8306

Conference Cast:

To access the live event or archive, use this URL:
https://im.csgsystems.com/cgi-bin/confCast
Enter Conference ID# 424231 
Then click Go.

Open Session

1. Call to Order.
    
2. Roll Call.
    
3. Consideration of applications submitted in response to CLIN 1: Partnering Opportunity for Late Stage Preclinical Projects.
   • Clinical March Presentation 
4. Consideration of applications submitted in response to the DISC1: Inception Awards.
   • Disc1: Inception Presentation
   • Disc1 Inception Summaries
   • Letter to the Board DISC1-09984
   • Letter to the Board DISC1-09999

Closed Session

5. Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to applications submitted in response to CLIN 1: Partnering Opportunity for Late Stage Preclinical Projects and the DISC1: Inception Awards (Health & Safety Code 125290.30(f) (3) (B) and (C)).
    
6. Public Comment.
    
7. Adjournment.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Maria Bonneville at the California Institute for Regenerative Medicine at 510-340-9111 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Maria Bonneville at the California Institute for Regenerative Medicine at mbonneville@cirm.ca.gov or 510-340-9111.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.

---